ストックスクリーナーアプリを入手
0.8398
2.02%
0.0166
前日終値:
$0.8232
開ける：
$0.8286
24時間の取引高:
491.90K
Relative Volume:
0.46
時価総額：
$108.48M
収益：
-
当期純損益:
$-26.91M
株価収益率:
-3.8173
EPS:
-0.22
ネットキャッシュフロー:
$-19.57M
1週間 パフォーマンス:
+6.57%
1か月 パフォーマンス:
+8.67%
6か月 パフォーマンス:
+17.18%
1年 パフォーマンス:
-44.01%
1日の値動き範囲:
$0.827
$0.8469
1週間の範囲:
$0.78
$0.8469
52週間の値動き範囲:
$0.5526
$1.66
Atossa Therapeutics Inc Stock (ATOS) Company Profile
名前
Atossa Therapeutics Inc
セクター
電話
206.588.0256
住所
10202 5TH AVENUE NE, SEATTLE, WA
ATOS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ATOS
Atossa Therapeutics Inc
|
0.8398 | 103.13M | 0 | -26.91M | -19.57M | -0.22 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Atossa Therapeutics Inc Stock (ATOS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2018-01-26 | 開始されました | Maxim Group | Buy |
Atossa Therapeutics Inc (ATOS) 最新ニュース
Will Atossa Therapeutics Inc. stock recover after recent dropJuly 2025 Earnings & Daily Risk Controlled Trade Plans - Newser
Real time breakdown of Atossa Therapeutics Inc. stock performanceTreasury Yields & Stepwise Trade Signal Guides - Newser
Full technical analysis of Atossa Therapeutics Inc. stock2025 Trade Ideas & Weekly Hot Stock Watchlists - Newser
Atossa Therapeutics Inc.’s volatility index tracking explainedBear Alert & Fast Moving Stock Trade Plans - Newser
How to build a dashboard for Atossa Therapeutics Inc. stockWatch List & Fast Entry Momentum Alerts - Newser
Will Atossa Therapeutics Inc. stock go up soon2025 Bull vs Bear & Daily Volume Surge Signals - Newser
What to expect from Atossa Therapeutics Inc. in the next 30 daysRecession Risk & Safe Entry Point Identification - Newser
Can technical indicators confirm Atossa Therapeutics Inc.’s reversalJuly 2025 Sentiment & Expert Verified Movement Alerts - Newser
Ranking Atossa Therapeutics Inc. among high performing stocks via toolsWeekly Stock Recap & Free Expert Verified Stock Movement Alerts - Newser
NioCorp and Atossa Therapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Livingston Daily
What recovery options are there for Atossa Therapeutics Inc.Stop Loss & Fast Gain Stock Trading Tips - Newser
Custom watchlist performance reports with Atossa Therapeutics Inc.2025 Technical Overview & Low Drawdown Trading Strategies - Newser
Key metrics from Atossa Therapeutics Inc.’s quarterly dataGap Down & Verified Momentum Stock Watchlist - Newser
Analyzing drawdowns of Atossa Therapeutics Inc. with statistical tools2025 Momentum Check & Expert Verified Movement Alerts - Newser
Leading vs lagging indicators on Atossa Therapeutics Inc. performance2025 Earnings Surprises & Technical Buy Zone Confirmations - Newser
Using economic indicators to assess Atossa Therapeutics Inc. potential2025 Short Interest & Verified Technical Signals - Newser
Atossa Therapeutics Receives Nasdaq Non-Compliance Notice - MSN
How to escape a deep drawdown in Atossa Therapeutics Inc.Forecast Cut & Daily Entry Point Trade Alerts - Newser
Has Atossa Therapeutics Inc. found a price floorJuly 2025 Review & Long Hold Capital Preservation Plans - Newser
analyzing drawdowns of atossa therapeutics inc. with statistical toolsOptions Play & Low Drawdown Investment Ideas - Newser
Using data models to predict Atossa Therapeutics Inc. stock movementJuly 2025 Catalysts & Daily Risk Controlled Trade Plans - Newser
What does recent volatility data suggest for Atossa Therapeutics Inc.July 2025 Levels & Safe Capital Investment Plans - Newser
H.C. Wainwright Maintains Atossa Therapeutics(ATOS.US) With Buy Rating, Maintains Target Price $7 - 富途牛牛
Atossa Genetics stock rating reiterated by H.C. Wainwright on FDA meeting plans - Investing.com Australia
Institutional scanner results for Atossa Therapeutics Inc.2025 Buyback Activity & Expert Approved Trade Ideas - Newser
Atossa at H.C. Wainwright: Zinhoxifen’s Dual Pathway Strategy By Investing.com - Investing.com Canada
Atossa Therapeutics Inc. Shows Early Signs of Technical StrengthJuly 2025 Final Week & Free Low Drawdown Momentum Trade Ideas - beatles.ru
Atossa Therapeutics Inc (ATOS) 財務データ
収益
当期純利益
現金流量
EPS
0.93%
0.10%
大文字化:
|
ボリューム (24 時間):